Catalyst Wire Dossier Catalyst Wire Dossier

GLARS-NF1 Tablet

GLA5PR · GL Pharm Tech Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLARS-NF1 Tablet, covering 2014-12-30 to 2014-12-30. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Open-label, Single Dose, Parallel Study to Evaluate the Pharmacokinetics Dose Proportionality of GLA5PR GLARS-NF1 Tablet in Healthy Male Volunteers [Phase 1]

See pricing